FDA commends Pakistan's efforts in strengthening drug regulatory infrastructure.

ISLAMABAD -- United States Food and Drug Administration (FDA) has commended the efforts of Pakistan in strengthening its drug regulatory infrastructure and recognized the significant progress made in recent years.

During a meeting with Minister for National Health Services, Regulations and Coordination, Abdul Qadir Patel, the officials from the FDA highlighted the importance of collaboration between regulatory authorities to ensure the safety, efficacy, and quality of pharmaceutical products, both domestically and internationally.

Minister for National Health Services, Regulations and Coordination, Abdul Qadir Patel, who visited the United States Food and Drug Administration headquarters in Maryland, conducted a productive meeting with officials of the FDA.

He expressed that the interaction would bring a positive outcome and this marks a significant milestone in our efforts to enhance drug regulation in Pakistan. He said, 'We are committed to fostering strong partnerships with international counterparts to strengthen our regulatory processes, ensure patient safety, and contribute to global health objectives."

The meeting aimed to strengthen bilateral cooperation in the field of pharmaceutical regulation and foster collaborative efforts between the two nations in ensuring the safety and quality of medicinal products, especially curtailing the menace of spurious and sub-standard medicines and capacity building of DRAP.

During the meeting, Qadir Patel expressed his gratitude for the warm...